Briefly, there are two principle mechanisms though which tumor cells mount IFN-γ resistance: 1) disruption in the primary signaling pathway, IFNGR/JAK/STAT, responsible for effector functions of IFN-γ stimulation; and 2) epigenetic or regulatory background leading to favorable expression of some ISGs over others. Here, IFNGR1 is linked to neoplasm.